Goldman Sachs’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,660
| Closed | -$35K | – | 5390 |
|
|
2020
Q4 | $35K | Buy |
+1,660
| New | +$35K | ﹤0.01% | 4590 |
|
|
2020
Q3 | – | Sell |
-1,249
| Closed | -$29K | – | 4586 |
|
|
2020
Q2 | $29K | Buy |
+1,249
| New | +$29K | ﹤0.01% | 4291 |
|
|
2018
Q3 | – | Sell |
-597
| Closed | -$65K | – | 4265 |
|
|
2018
Q2 | $65K | Buy |
+597
| New | +$65K | ﹤0.01% | 4045 |
|
|
2017
Q3 | – | Sell |
-1,875
| Closed | -$418K | – | 4435 |
|
|
2017
Q2 | $418K | Buy |
+1,875
| New | +$418K | ﹤0.01% | 3628 |
|